•
Dec 31, 2018

ResMed Q2 2019 Earnings Report

Total Revenue
$651M
Previous year: $601M
+8.3%
EPS
$1
Previous year: $1
+0.0%
Gross Profit
$384M
Previous year: $350M
+9.7%
Cash and Equivalents
$149M
Previous year: $859M
-82.6%
Free Cash Flow
$111M
Previous year: $117M
-4.8%
Total Assets
$3.86B
Previous year: $3.56B
+8.3%

ResMed

ResMed